Project Number 1R41AG077992-01 Agency/Funding Organization NIA Funding Year 2022 View Full Project Details for APOE-targeted therapy for precision medicine in late onset Alzheimer's disease: A novel epigenome editing approach for downregulation of APOEe4 expression Research Categorization Primary Disease / Condition Alzheimer's Disease CADRO Category C. Translational Research and Clinical Interventions 3. Drug Discovery (small molecules and biologics) c. ApoE, Lipids and Lipoprotein Receptors Researcher and Organization Principal Investigator CHIBA-FALEK, ORNIT Principal Investigator First Name ORNIT Principal Investigator Last Name CHIBA-FALEK Awardee Organization CLAIRIGENE, LLC Awardee State North Carolina Contact PI Country United States Project Detail Funding Opportunity Announcement PAS-19-317: Advancing Research on Alzheimer's Disease (AD) and Alzheimer's-Disease-Related Dementias (ADRD) (R41/R42 Clinical Trial Optional) FY Overall Cost $492,903 Funding Organization Agency/Funding Organization NIA Funding Organization Country United States Program Official MARTIN, ZANE
